Drug Discovery 2017
Poster
137

Novel first-in-class selective IKKα inhibitors as anti-cancer drugs

Objective

The aim of this work was to study the potential effect of inhibitory kappa B kinase α (IKKα) inhibitors as potential anti-cancer drugs.

supporting document

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2038